Finalist
Myeloproliferative Neoplasms Virtual Speaker Training Program 2021
with support from Langland
Summary of work
People with myeloproliferative neoplasms (MPNs) in the Asia, Middle East and Africa region are often sub-optimally managed. Market research has shown this to be a result of a lack of understanding of the significant correlation between disease severity and psychosocial burden on the patient, and poor symptom monitoring by both the patient and healthcare professionals.
The pandemic created a rapid shift in the way haematologists engaged with medical education and how they communicated with their patients, requiring effective delivery through virtual challenges.
A pool of regional virtual educators was rapidly needed to deliver patient-centric education on the latest treatment data and clinical best practice in MPN management, while navigating the clinical and cultural nuances of the region. An educational program tailored to the clinical needs of this diverse region was required to support haematologists advance the quality of care for patients with MPNs ensuring clear understanding of the role ruxolitinib can play in improving patient outcomes and changing patients’ lives. As the impact of the pandemic became clear, it was evident that education needed to embrace virtual channels and overcome the emerging hurdles of digital engagement.
Judges’ comments
This entry made good use of digital channels for emerging markets. It was well thought through, designed well and professionally executed. To improve upon this entry, the judges felt that they needed to see something different that hadn’t been done before and the objectives needed to be SMART.
